Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Compass Therapeutics Inc (CMPX)

Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Compass Therapeutics Inc 80 GUEST STREET SUITE 601 BOSTON MA 02135 USA

www.compasstherapeutics.com Employees: 35 P: 617-500-8099

Sector:

Medical

Description:

Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.

Key Statistics

Overview:

Market Capitalization, $K 373,364
Enterprise Value, $K 329,884
Shares Outstanding, K 138,283
Annual Sales, $ 850 K
Annual Net Income, $ -49,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -16,630 K
EBIT, $ -61,830 K
EBITDA, $ -61,730 K
60-Month Beta 1.48
% of Insider Shareholders 29.80%
% of Institutional Shareholders 68.43%
Float, K 97,075
% Float 70.20%
Short Volume Ratio 0.66

Growth:

1-Year Return 159.62%
3-Year Return -3.57%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 05/08/25
Next Earnings Date 08/11/25
Earnings Per Share ttm -0.41
EPS Growth vs. Prev Qtr -9.09%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CMPX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.47%
Return-on-Assets % -38.31%
Profit Margin % -5,809.41%
Debt/Equity 0.00
Price/Sales 463.65
Price/Cash Flow N/A
Price/Book 3.57
Book Value/Share 0.80
Interest Coverage -2.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar